Navigation Links
Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting
Date:6/1/2008

clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at the ASCO meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
2. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
3. Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
4. Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
5. Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting
6. Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
7. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
8. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
9. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
10. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
11. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DALLAS , Sept. 18, 2014 /PRNewswire-iReach/ -- ... and China Acetic Acid Industry" and "2014 Deep ... Industry" reports to its research database. ... 2014 Deep Research Report on Global and China ... research report on China ...
(Date:9/18/2014)... Washington, D.C. (PRWEB) September 18, 2014 ... Dick Durbin and Sen. Jim Risch for National Lab ... research projects from across the national laboratory system. Durbin ... Caucus, which aims to increase awareness of the reach ... breakthrough technologies and discoveries to address some of our ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Leatherwood ... FM-4910 listed material, to stay competitive in the ... These high-performance materials ultimately impact product quality and ... and owner. , Established in 1980 in Lewisville, ... as many fabricators have left the business. Much ...
(Date:9/18/2014)... 18 septembre 2014 Mapi, société créée ... 1974, a été depuis 40 ans l,un ... cliniques traditionnelles par des évaluations recentrées sur ... les impacts économiques des traitements. ... A cours d,une récente conférence téléphonique ...
Breaking Biology Technology:Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 2Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 3Acetic Acid Market & Sodium Stannate Industry (China, Global) Research Report 4Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 21974 - 2014 - Mapi fête ses 40 ans 2
... Approved for peripheral neuropathic pain in non-diabetic adultsSAN ... NGSX ), a biopharmaceutical company focused ... announced today that the European Commission has formally ... patch (formerly NGX-4010) for the treatment of peripheral ...
... in Waikoloa, Hawaii, has just installed the trailblazing new ... their restaurants, brown grease waste into clear water - ... a cost-cutting and "green" service is a business smart ... GRS drastically reduces the need to pump and haul ...
... Pa., May 20 Cephalon, Inc. (Nasdaq: ... subject to market and other conditions, $300 million of common ... senior subordinated notes due 2014 through two concurrent public offerings. ... to cover over-allotments, to purchase up to an additional $45 ...
Cached Biology Technology:NeurogesX Receives European Commission Approval for Qutenza(TM) 2NeurogesX Receives European Commission Approval for Qutenza(TM) 3NeurogesX Receives European Commission Approval for Qutenza(TM) 4NeurogesX Receives European Commission Approval for Qutenza(TM) 5Marriott Resort Magically Turns Brown Grease "Green" With The Cost-Cutting Hydrologix GRS 2Marriott Resort Magically Turns Brown Grease "Green" With The Cost-Cutting Hydrologix GRS 3Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 2Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 3Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 4Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes 5
(Date:9/18/2014)... A new GSA Bulletin study uses tree ... Puerco and Chaco Wash in northern New Mexico, USA. ... cedar and willow, investigators were able to precisely date ... then combined this data with aerial imagery, LiDAR, longitudinal ... these arroyos. , Arroyos are deep, oversized channels that ...
(Date:9/18/2014)... a small, icy moon of Uranus, is one of ... solar system. Despite its relatively small size, Miranda appears ... resulted in the formation of at least three remarkable ... , These coronae are visible in Miranda,s southern ... across. Arden corona, the largest, has ridges and troughs ...
(Date:9/18/2014)... system that can operate inside the bore of an ... a biomedical research partnership program at Brigham and Women,s ... the robot, in conjunction with real-time MRI images, can ... and less discomforting for the patient. The novel system ... with greater precision. , Developed by a team of ...
Breaking Biology News(10 mins):Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Miranda: An icy moon deformed by tidal heating 2Miranda: An icy moon deformed by tidal heating 3Miranda: An icy moon deformed by tidal heating 4Miranda: An icy moon deformed by tidal heating 5Miranda: An icy moon deformed by tidal heating 6Miranda: An icy moon deformed by tidal heating 7Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5
... Research Institute (NSBRI) has selected Daniela Trani, PhD, ... four young investigators in the nation for its ... postdoctoral fellow in Georgetown,s Lombardi Comprehensive Cancer Center ... & Cellular Biology. In the NSBRI, the ...
... Ga. Another 200 newborns in Georgia and Florida ... enrolled over the next year in a long-term study ... A $10 million, five-year grant renewal from the ... as well as ongoing monitoring of participants from the ...
... color to the ancestral line of parasitic bacteria, scientists can ... revealed where you lived or who you spent time with. ... how to look. Stanford researchers with collaborators at Tel-Aviv ... window to the past using a technique called "reverse ecology." ...
Cached Biology News:GUMC young scientist selected postdoc Fellow at National Space Biomedical Research Institute 2Study examining role of genetics and environment in type 1 diabetes 2Study examining role of genetics and environment in type 1 diabetes 3Reversing ecology reveals ancient environments 2
... 500 optimization kit is for fine-tuning the ... The kit is recommended when you are ... The kit includes 0.25 g each of ... diameter gold microcarriers, 100 each of 9 ...
... used to test the crossreactivity of an ... are commonly used as blocking reagents or ... 21 different protein preparations on a nitrocellulose ... species specificity, QC of purified antibodies, selection ...
... microplate coating using advanced automated high throughput microplate processing equipment ... can also accommodate virtually any lot size of the following ... 8 and 12 well strips, ... 384 well microplate, ...
...
Biology Products: